Hepatic immune cell environment in colorectal liver metastasis
- Conditions
- C78.7Secondary malignant neoplasm of liver and intrahepatic bile duct
- Registration Number
- DRKS00031112
- Lead Sponsor
- Klinik für Allg., Viszeral- und Transplantationschirurgie, Uniklinik RWTH Aachen
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
1. Male or female patients undergoing liver surgery for colorectal liver metastases
2. Age = 18 years
3. Informed consent for study participation
4. Available preoperative cross-sectional imaging for sarcopenia measurement
Exclusion Criteria
1. Any factors compromising the ability of the patient to cooperate and follow study protocol (e.g. impaired cognitive function or active drug abuse)
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Quantity, quality and activation status of hepatic immune cells
- Secondary Outcome Measures
Name Time Method Sarcopenia in patients with colorectal liver metastases